162 related articles for article (PubMed ID: 23552557)
1. MLK4β functions as a negative regulator of MAPK signaling and cell invasion.
Abi Saab WF; Brown MS; Chadee DN
Oncogenesis; 2012 Mar; 1(3):e6. PubMed ID: 23552557
[TBL] [Abstract][Full Text] [Related]
2. Osmotic and heat stress-dependent regulation of MLK4β and MLK3 by the CHIP E3 ligase in ovarian cancer cells.
Blessing NA; Kasturirangan S; Zink EM; Schroyer AL; Chadee DN
Cell Signal; 2017 Nov; 39():66-73. PubMed ID: 28757353
[TBL] [Abstract][Full Text] [Related]
3. Cloning and Initial Functional Characterization of Mlk4α and Mlk4β.
Kashuba VI; Grigorieva EV; Kvasha SM; Pavlova TV; Grigoriev V; Protopopov A; Kharchenko O; Gizatullin R; Rynditch AV; Zabarovsky ER
Genomics Insights; 2011; 4():1-12. PubMed ID: 26217104
[TBL] [Abstract][Full Text] [Related]
4. Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family.
Teramoto H; Coso OA; Miyata H; Igishi T; Miki T; Gutkind JS
J Biol Chem; 1996 Nov; 271(44):27225-8. PubMed ID: 8910292
[TBL] [Abstract][Full Text] [Related]
5. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA
J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580
[TBL] [Abstract][Full Text] [Related]
6. Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells.
Zhan Y; Abi Saab WF; Modi N; Stewart AM; Liu J; Chadee DN
Exp Cell Res; 2012 Aug; 318(14):1641-8. PubMed ID: 22652451
[TBL] [Abstract][Full Text] [Related]
7. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells.
Kim KY; Kim BC; Xu Z; Kim SJ
J Biol Chem; 2004 Jul; 279(28):29478-84. PubMed ID: 15069087
[TBL] [Abstract][Full Text] [Related]
8. The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis.
Xu Z; Maroney AC; Dobrzanski P; Kukekov NV; Greene LA
Mol Cell Biol; 2001 Jul; 21(14):4713-24. PubMed ID: 11416147
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin.
Zhan Y; Chadee DN
Small GTPases; 2010 Nov; 1(3):183-186. PubMed ID: 21686274
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of mixed lineage kinases in dendritic cells.
Handley ME; Rasaiyaah J; Barnett J; Thakker M; Pollara G; Katz DR; Chain BM
Int Immunol; 2007 Aug; 19(8):923-33. PubMed ID: 17698565
[TBL] [Abstract][Full Text] [Related]
12. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.
Swantek JL; Cobb MH; Geppert TD
Mol Cell Biol; 1997 Nov; 17(11):6274-82. PubMed ID: 9343388
[TBL] [Abstract][Full Text] [Related]
13. Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.
Mishra P; Senthivinayagam S; Rangasamy V; Sondarva G; Rana B
Mol Endocrinol; 2010 Mar; 24(3):598-607. PubMed ID: 20150185
[TBL] [Abstract][Full Text] [Related]
14. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
Cronan MR; Nakamura K; Johnson NL; Granger DA; Cuevas BD; Wang JG; Mackman N; Scott JE; Dohlman HG; Johnson GL
Oncogene; 2012 Aug; 31(34):3889-900. PubMed ID: 22139075
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer.
Zhan Y; Modi N; Stewart AM; Hieronimus RI; Liu J; Gutmann DH; Chadee DN
Oncogene; 2011 Feb; 30(7):781-9. PubMed ID: 20890305
[TBL] [Abstract][Full Text] [Related]
16. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Muniyappa H; Das KC
Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
[TBL] [Abstract][Full Text] [Related]
17. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
18. Involvement of mixed lineage kinase 3 in cancer.
Chadee DN
Can J Physiol Pharmacol; 2013 Apr; 91(4):268-74. PubMed ID: 23627838
[TBL] [Abstract][Full Text] [Related]
19. LATS1 Regulates Mixed-Lineage Kinase 3 (MLK3) Subcellular Localization and MLK3-Mediated Invasion in Ovarian Epithelial Cells.
Kasturirangan S; Mehdi B; Chadee DN
Mol Cell Biol; 2021 Jun; 41(7):e0007821. PubMed ID: 33875576
[TBL] [Abstract][Full Text] [Related]
20. MLK3 Signaling in Cancer Invasion.
Rattanasinchai C; Gallo KA
Cancers (Basel); 2016 May; 8(5):. PubMed ID: 27213454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
